Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 6:46 pm Unchanged | 13G | SPYRE THERAPEUTICS, INC SYRE | BCLS II Equity Opportunities LP | 0 0% | 0 (Unchanged) | View |
| 2023-02-14 06:04 am Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BCLS II Equity Opportunities LP | 5,347,689 8.7% | 2,500,000 (+87.79%) | View |
| 2022-02-14 06:40 am Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BCLS II Equity Opportunities LP | 2,847,689 5.8% | 147,689 (+5.47%) | View |
| 2020-06-09 11:45 am Purchase | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BCLS II Equity Opportunities LP | 2,700,000 6.1% | 2,700,000 (New Position) | View |